Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject for Iron Deficiency in Non-Anaemic CKD Patients
NCT04862715Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by King's College Hospital. Started Apr 2019; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04862715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04862715.